Atlas Trials

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

RecordFirmDate
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma (NCT07691450)City of Hope Medical Center2027-01-03
Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas (NCT04774068)Walter Hanel2021-09-01
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998)City of Hope Medical Center2019-02-04
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma (NCT03534180)City of Hope Medical Center2018-08-21
Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03210662)M.D. Anderson Cancer Center2018-02-01
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625)National Cancer Institute (NCI)2017-09-27
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma (NCT02520791)National Cancer Institute (NCI)2016-09-13

Track Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.